View in EDS HTML Full Text PDF Full Text

Real-world experience of using dupilumab and JAK inhibitors to manage pruritus in epidermolysis bullosa pruriginosa.

Saved in:
Bibliographic Details
Title: Real-world experience of using dupilumab and JAK inhibitors to manage pruritus in epidermolysis bullosa pruriginosa.
Authors: Hou PC; Department of Dermatology National Cheng Kung University Hospital College of Medicine National Cheng Kung University Tainan Taiwan., Aala W Jr; Institute of Clinical Medicine College of Medicine National Cheng Kung University Tainan Taiwan., Tu WT; Department of Dermatology National Cheng Kung University Hospital College of Medicine National Cheng Kung University Tainan Taiwan., McGrath JA; Department of Dermatology National Cheng Kung University Hospital College of Medicine National Cheng Kung University Tainan Taiwan.; St John's Institute of Dermatology School of Basic and Medical Biosciences King's College London London UK., Hsu CK; Department of Dermatology National Cheng Kung University Hospital College of Medicine National Cheng Kung University Tainan Taiwan.; Institute of Clinical Medicine College of Medicine National Cheng Kung University Tainan Taiwan.; International Center for Wound Repair and Regeneration National Cheng Kung University Tainan Taiwan.
Source: Skin health and disease [Skin Health Dis] 2024 Aug 19; Vol. 4 (5), pp. e445. Date of Electronic Publication: 2024 Aug 19 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9918227353706676 Publication Model: eCollection Cited Medium: Internet ISSN: 2690-442X (Electronic) Linking ISSN: 2690442X NLM ISO Abbreviation: Skin Health Dis Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39355753
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Real-world experience of using dupilumab and JAK inhibitors to manage pruritus in epidermolysis bullosa pruriginosa.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Hou+PC%22">Hou PC</searchLink>; Department of Dermatology National Cheng Kung University Hospital College of Medicine National Cheng Kung University Tainan Taiwan.<br /><searchLink fieldCode="AU" term="%22Aala+W+Jr%22">Aala W Jr</searchLink>; Institute of Clinical Medicine College of Medicine National Cheng Kung University Tainan Taiwan.<br /><searchLink fieldCode="AU" term="%22Tu+WT%22">Tu WT</searchLink>; Department of Dermatology National Cheng Kung University Hospital College of Medicine National Cheng Kung University Tainan Taiwan.<br /><searchLink fieldCode="AU" term="%22McGrath+JA%22">McGrath JA</searchLink>; Department of Dermatology National Cheng Kung University Hospital College of Medicine National Cheng Kung University Tainan Taiwan.; St John's Institute of Dermatology School of Basic and Medical Biosciences King's College London London UK.<br /><searchLink fieldCode="AU" term="%22Hsu+CK%22">Hsu CK</searchLink>; Department of Dermatology National Cheng Kung University Hospital College of Medicine National Cheng Kung University Tainan Taiwan.; Institute of Clinical Medicine College of Medicine National Cheng Kung University Tainan Taiwan.; International Center for Wound Repair and Regeneration National Cheng Kung University Tainan Taiwan.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229918227353706676%22">Skin health and disease</searchLink> [Skin Health Dis] 2024 Aug 19; Vol. 4 (5), pp. e445. <i>Date of Electronic Publication: </i>2024 Aug 19 (<i>Print Publication: </i>2024).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9918227353706676 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2690-442X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222690442X%22">2690442X </searchLink><i>NLM ISO Abbreviation: </i>Skin Health Dis <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39355753
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/ski2.445
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e445
    Titles:
      – TitleFull: Real-world experience of using dupilumab and JAK inhibitors to manage pruritus in epidermolysis bullosa pruriginosa.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Hou PC
      – PersonEntity:
          Name:
            NameFull: Aala W Jr
      – PersonEntity:
          Name:
            NameFull: Tu WT
      – PersonEntity:
          Name:
            NameFull: McGrath JA
      – PersonEntity:
          Name:
            NameFull: Hsu CK
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 19
              M: 08
              Text: 2024 Aug 19
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2690-442X
          Numbering:
            – Type: volume
              Value: 4
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Skin health and disease
              Type: main
ResultId 1